- Super PBM merger approved; NACDS, NCPA file emergency motion to block merger
- FTC staff report attacks branded-generic patent settlements
- FTC requests additional information on ESI-Medco merger
- N.Y. state mail-order bill would raise drug costs, reduce access, FTC says
- Report: FTC to rule on Express Scripts, Medco merger within 30 days
WASHINGTON — A coalition of consumer groups on Tuesday joined its collective voice to the number of constituents opposing the Express Scripts-Medco merger in a letter to the Federal Trade Commission, according to a report filed by Reuters.
"Health plans have distinctly different interests, and thus have not been adequate protectors of consumer concerns," they wrote in the letter addressing FTC chairman Jon Leibowitz. "As the PBM market continues to consolidate, health plans will only become less able to protect consumers. This merger will create a dominant PBM with the market power and leverage to effectively force plans into restricted networks that will ultimately harm consumers."
The coalition included the Consumer Federation of America, Community Catalyst, the National Consumers League, the National Legislative Association on Prescription Drug Prices and U.S. PIRG, the federation of state Public Interest Research Groups.
For the full report, click here.